PFProf. Eitan Friedman
Director and founder of the Suzanne Levy-Gertner Oncogenetics Unit · Director
At a glance
Core facts about the doctor and the hospital, as provided by the hospital.
3 areasSpecialties: Internal Medicine, Hematology…
HematologyCategory
English, HebrewLanguages
JCIAccredited hospital · Tel Hashomer
72 staffListed at this hospital
Prof. Arnon Nagler is a Director of the Division of Hematology at Sheba Medical Center in Tel Hashomer, Israel, a JCI-accredited center. Lists Internal Medicine, Hematology and BMT.
About
Arnon Nagler, M.D., M.Sc., is director of both the Division of Hematology and the Bone Marrow Transplantation and Cord Blood Bank at the Chaim Sheba Medical Center, Tel-Hashomer, Israel and Professor of Medicine at The Tel Aviv University, Tel-Aviv, Israel.
Prof. Nagler received his medical training at the Hebrew University-Hadassah Medical School, Jerusalem, Israel, specializing in Internal Medicine and Haematology at the Rambam Medical Center, Haifa, and in Hematopoiesis (MSc) in TA University, Israel. He carried out a Postdoctoral research fellowship in hematology and bone marrow transplantation at “Stanford University Hospital” Palo Alto, CA, in the USA, from 1986 to 1990.
Prof. Nagler has been working in the fields of bone marrow transplantation for haematological malignancies, for the last 25 years. Prof. Nagler is one of the pioneeres of the non myeloablative and reduced intensity/toxicity allogeneic transplantations for both malignant and non-malignant disorders (Blood 1998). His main contributions and scientific interests include hematpoietic stem cell transplantation, haematological malignancies, cord blood biology and transplantation and adoptive cell-mediated immunotherapy including NK cell biology.
Prof. Nagler established the first public cord blood bank in Israel and performed the first cord blood transplantations from related and unrelated donors in genetic and malignant hematological diseases in Israel.
Prof. Nagler is active member of the EBMT since 1993. In 2001 EBMT Annual meeting (Maastricht, the Netherland) his study on IL-18 for GVHD in mice model was chosen for presentation at the presidential symposium. Over the years he was invited speaker in several of the EBMT meetings. Dr Nagler served as the leader of the Alternative donor subcommittee of the ALWP of the EBMT from 2008-2010 and from 2010 he is the leader of the RIC subcommittee of the ALWP of the EBMT.
Prof. Nagler serves on the Board o
Prof. Nagler received his medical training at the Hebrew University-Hadassah Medical School, Jerusalem, Israel, specializing in Internal Medicine and Haematology at the Rambam Medical Center, Haifa, and in Hematopoiesis (MSc) in TA University, Israel. He carried out a Postdoctoral research fellowship in hematology and bone marrow transplantation at “Stanford University Hospital” Palo Alto, CA, in the USA, from 1986 to 1990.
Prof. Nagler has been working in the fields of bone marrow transplantation for haematological malignancies, for the last 25 years. Prof. Nagler is one of the pioneeres of the non myeloablative and reduced intensity/toxicity allogeneic transplantations for both malignant and non-malignant disorders (Blood 1998). His main contributions and scientific interests include hematpoietic stem cell transplantation, haematological malignancies, cord blood biology and transplantation and adoptive cell-mediated immunotherapy including NK cell biology.
Prof. Nagler established the first public cord blood bank in Israel and performed the first cord blood transplantations from related and unrelated donors in genetic and malignant hematological diseases in Israel.
Prof. Nagler is active member of the EBMT since 1993. In 2001 EBMT Annual meeting (Maastricht, the Netherland) his study on IL-18 for GVHD in mice model was chosen for presentation at the presidential symposium. Over the years he was invited speaker in several of the EBMT meetings. Dr Nagler served as the leader of the Alternative donor subcommittee of the ALWP of the EBMT from 2008-2010 and from 2010 he is the leader of the RIC subcommittee of the ALWP of the EBMT.
Prof. Nagler serves on the Board o
Education
- M.D. certification from the Hebrew University-Hadassah Medical School, JerusalemSpecialized in Internal Medicine and Haematology at the Rambam Medical Center, HaifaMSc. specialization in Hematopoiesis in TA University, IsraelPostdoctoral research fellowship in hematology and bone marrow transplantation at "Stanford University Hospital" Palo Alto, CA, in the USA, from 1986 to 1990.
Professional Experience
- Director of the Division of Hematology, Sheba Medical CenterDirector of Bone Marrow transplantation and Cord Blood Bank, Sheba Medical CenterProfessor of Medicine at the Tel Aviv UniversityChair of the ALWP of the EBMT-since 2014coChair Scientific Council of the EBMT –since 2016Active member of the EBMT since 1993Leader of the Alternative donor subcommittee of the ALWP of the EBMT from 2008-2010Leader of the RIC subcommittee of the ALWP of the EBMT –2010-2014Member of multiple national and international societies and committeesServes on the Editorial Board of several BMT and Hematology Journals and is a Section Editor for Leukemia
Ask the doctor's team about your case
Send your reports and questions to Sheba Medical Center. The hospital replies through Health-Tourism.com.
Free consultation • No obligation • Direct communication with the hospital
